Polycystic ovary syndrome classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:
==Classification==
==Classification==
Two definitions are commonly used:
Two definitions are commonly used:
#In 1990 a consensus workshop sponsored by the [[NIH]]/[[NICHD]] suggested that a patient has PCOS if she has (1) signs of [[androgen]] excess (clinical or biochemical), (2) [[oligoovulation]], and (3) other entities are excluded  that would cause polycystic ovaries.
*In 1990 a consensus workshop sponsored by the [[NIH]]/[[NICHD]] suggested that a patient has PCOS if she has
#In 2003 a consensus workshop sponsored by [[ESHRE]]/[[ASRM]] in Rotterdam indicated PCOS to be present if 2 out of 3 criteria are met: (1) [[oligoovulation]] and/or [[anovulation]], (2) excess androgen activity, (3) polycystic ovaries (by [[gynecologic ultrasound]]), and other causes of PCOS are excluded.
**Signs of [[androgen]] excess (clinical or biochemical)
 
**[[Oligoovulation]]
**Other entities are excluded  that would cause polycystic ovaries.
*In 2003 a consensus workshop sponsored by [[ESHRE]]/[[ASRM]] in Rotterdam indicated PCOS to be present if 2 out of 3 criteria are met: <ref name="pmid14711538">{{cite journal |vauthors= |title=Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome |journal=Fertil. Steril. |volume=81 |issue=1 |pages=19–25 |year=2004 |pmid=14711538 |doi= |url=}}</ref>
**[[Oligoovulation]] and/or [[anovulation]]
**Excess androgen activity
**Polycystic ovaries (by [[gynecologic ultrasound]]), and other causes of PCOS are excluded.
The Rotterdam definition is wider, including many more patients, notably patients without androgen excess, whereas in the NIH/NICHD definition androgen excess is a prerequisite. Critics maintain that findings obtained from the study of patients with androgen excess cannot necessarily be extrapolated to patients without androgen excess.
The Rotterdam definition is wider, including many more patients, notably patients without androgen excess, whereas in the NIH/NICHD definition androgen excess is a prerequisite. Critics maintain that findings obtained from the study of patients with androgen excess cannot necessarily be extrapolated to patients without androgen excess.
*PCOS is also classified based upon severity of symptoms into<ref name="pmid2893212">{{cite journal |vauthors=Jackson JR |title=Toxicity of herbicide containing glyphosate |journal=Lancet |volume=1 |issue=8582 |pages=414 |year=1988 |pmid=2893212 |doi= |url=}}</ref>
**'''Asymptomatic form''': women with only PCO morphology
**'''Mild form''': PCO morphology along with anovulation
**'''Classical form''': Hyperandogenism along with ovarian dysfunction (anovulation and / or PCO)
**'''Metabolic form''': Combination of mild and classical forms with presence of obesity and/or insulin resistance (abdominal obesity, insülin resistance, raised waist / hip ratio)


==References==
==References==

Revision as of 19:20, 24 July 2017

Polycystic ovary syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polycystic ovary syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polycystic ovary syndrome classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycystic ovary syndrome classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycystic ovary syndrome classification

CDC on Polycystic ovary syndrome classification

Polycystic ovary syndrome classification in the news

Blogs on Polycystic ovary syndrome classification

Directions to Hospitals Treating Polycystic ovary syndrome

Risk calculators and risk factors for Polycystic ovary syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Classification

Two definitions are commonly used:

  • In 1990 a consensus workshop sponsored by the NIH/NICHD suggested that a patient has PCOS if she has
    • Signs of androgen excess (clinical or biochemical)
    • Oligoovulation
    • Other entities are excluded that would cause polycystic ovaries.
  • In 2003 a consensus workshop sponsored by ESHRE/ASRM in Rotterdam indicated PCOS to be present if 2 out of 3 criteria are met: [1]

The Rotterdam definition is wider, including many more patients, notably patients without androgen excess, whereas in the NIH/NICHD definition androgen excess is a prerequisite. Critics maintain that findings obtained from the study of patients with androgen excess cannot necessarily be extrapolated to patients without androgen excess.

  • PCOS is also classified based upon severity of symptoms into[2]
    • Asymptomatic form: women with only PCO morphology
    • Mild form: PCO morphology along with anovulation
    • Classical form: Hyperandogenism along with ovarian dysfunction (anovulation and / or PCO)
    • Metabolic form: Combination of mild and classical forms with presence of obesity and/or insulin resistance (abdominal obesity, insülin resistance, raised waist / hip ratio)

References

  1. "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome". Fertil. Steril. 81 (1): 19–25. 2004. PMID 14711538.
  2. Jackson JR (1988). "Toxicity of herbicide containing glyphosate". Lancet. 1 (8582): 414. PMID 2893212.


Template:WikiDoc Sources